BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29224677)

  • 1. Diagnostic and prognostic tests in systemic lupus erythematosus.
    Vasquez-Canizares N; Wahezi D; Putterman C
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):351-363. PubMed ID: 29224677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus.
    Tan G; Baby B; Zhou Y; Wu T
    Front Immunol; 2021; 12():808839. PubMed ID: 35095896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The applied basic research of systemic lupus erythematosus based on the biological omics.
    Sui W; Hou X; Che W; Yang M; Dai Y
    Genes Immun; 2013 Apr; 14(3):133-46. PubMed ID: 23446742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in applying of multi-omics approaches in the research of systemic lupus erythematosus.
    Song W; Tang D; Chen D; Zheng F; Huang S; Xu Y; Yu H; He J; Hong X; Yin L; Liu D; Dai W; Dai Y
    Int Rev Immunol; 2020; 39(4):163-173. PubMed ID: 32138562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus.
    Zhu H; Luo H; Yan M; Zuo X; Li QZ
    Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):210-8. PubMed ID: 26415621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis.
    Qi S; Chen Q; Xu D; Xie N; Dai Y
    Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ-specific biomarkers in lupus.
    Wu H; Zeng J; Yin J; Peng Q; Zhao M; Lu Q
    Autoimmun Rev; 2017 Apr; 16(4):391-397. PubMed ID: 28212922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress in systemic lupus erythematosus from 2021 to 2022].
    Li YZ; Wu XC
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Aug; 25(8):785-790. PubMed ID: 37668024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arraying Autoantibodies in SLE - Lessons Learned.
    Wang L; Mohan C; Li QZ
    Curr Mol Med; 2015; 15(5):456-61. PubMed ID: 26122657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Biomarkers for Lupus Nephritis in the "OMICS" Era.
    Dias R; Hasparyk UG; Lopes MP; de Barros JLVM; Simões E Silva AC
    Curr Med Chem; 2021; 28(29):6011-6044. PubMed ID: 33583367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials.
    Zhao S; Long H; Lu Q
    Clin Rev Allergy Immunol; 2010 Aug; 39(1):3-9. PubMed ID: 19639427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
    Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
    Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics and Systemic Lupus Erythematosus: Unmet Needs.
    Meroni PL; Penatti AE
    Clin Rev Allergy Immunol; 2016 Jun; 50(3):367-76. PubMed ID: 26206675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
    Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
    Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
    Seelen MA; Trouw LA; Daha MR
    Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):619-24. PubMed ID: 14564199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic approaches for novel systemic lupus erythematosus (SLE) drug discovery.
    Li Y; Wu T
    Expert Opin Drug Discov; 2018 Aug; 13(8):765-777. PubMed ID: 29863906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunometabolomics provides a new perspective for studying systemic lupus erythematosus.
    Wu Y; Zhao M; Gong N; Zhang F; Chen W; Liu Y
    Int Immunopharmacol; 2023 May; 118():109946. PubMed ID: 36931174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMT-based quantitative proteomics analysis and potential serum protein biomarkers for systemic lupus erythematosus.
    Zhou G; Wei P; Lan J; He Q; Guo F; Guo Y; Gu W; Xu T; Liu S
    Clin Chim Acta; 2022 Sep; 534():43-49. PubMed ID: 35810799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new serum biomarker panels for systemic lupus erythematosus diagnosis.
    Ling HZ; Xu SZ; Leng RX; Wu J; Pan HF; Fan YG; Wang B; Xia YR; Huang Q; Shuai ZW; Ye DQ
    Rheumatology (Oxford); 2020 Jun; 59(6):1416-1425. PubMed ID: 31899518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined proteomics and single cell RNA-sequencing analysis to identify biomarkers of disease diagnosis and disease exacerbation for systemic lupus erythematosus.
    Li Y; Ma C; Liao S; Qi S; Meng S; Cai W; Dai W; Cao R; Dong X; Krämer BK; Yun C; Hocher B; Hong X; Liu D; Tang D; He J; Yin L; Dai Y
    Front Immunol; 2022; 13():969509. PubMed ID: 36524113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.